The alpha2C-adrenoceptor deletion322-325 variant and cold-induced vasoconstriction

Area of Science:

• Physiology
• Genetics
• Pharmacology

Background:

• Cold exposure triggers vasoconstriction, partly mediated by alpha(2C)-adrenoceptor (alpha(2C)-AR) activity.
• A common genetic variant, ADRA2C del322-325, significantly reduces alpha(2C)-AR function in vitro.

Purpose of the Study:

• To investigate if the ADRA2C del322-325 variant influences vasoconstriction response to local cold exposure.
• To test the hypothesis that individuals with this variant exhibit attenuated cold-induced vasoconstriction.

Main Methods:

• Laser Doppler flowmetry measured cutaneous digital blood flow in 31 subjects under controlled temperature conditions.
• Subjects underwent cycles of local heat and cold exposure to generate temperature-response curves.
• Key measures included minimal flux (E(min)) and temperatures for 50% and 90% flux reduction (ET(50), ET(90)).

Main Results:

• No significant differences in E(min), ET(50), or ET(90) were observed between individuals with different ADRA2C genotypes (ins/ins, ins/del, del/del).
• Genotypic variations did not impact vascular responses during heating and cooling cycles.

Conclusions:

• The ADRA2C del322-325 variant does not appear to affect the vascular system's sensitivity to local cold stimuli.
• Findings suggest this specific alpha(2C)-AR gene variant does not play a significant role in modulating cold-induced vasoconstriction.